Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Buy
85
AXON Quote, Financials, Valuation and Earnings
Last price:
$601.35
Seasonality move
:
8.75%
Day range:
$620.99 - $631.16
52-week range:
$273.52 - $715.99
Dividend yield:
0%
P/E ratio:
129.73x
P/S ratio:
23.42x
P/B ratio:
20.46x
Volume:
358.2K
Avg. volume:
588.9K
1-year change:
95.07%
Market cap:
$47.6B
Revenue:
$2.1B
EPS (TTM):
$4.79
Analysts' Opinion
-
Consensus RatingAxon Enterprise has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $665.10, Axon Enterprise has an estimated upside of 7.03% from its current price of $621.40.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $491.36 representing 100% downside risk from its current price of $621.40.
Fair Value
-
According to the consensus of 10 analysts, Axon Enterprise has 7.03% upside to fair value with a price target of $665.10 per share.
AXON vs. S&P 500
-
Over the past 5 trading days, Axon Enterprise has overperformed the S&P 500 by 1.66% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Axon Enterprise does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Axon Enterprise has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Axon Enterprise reported revenues of $575.1M.
Earnings Growth
-
Axon Enterprise has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Axon Enterprise reported earnings per share of $1.67.
Enterprise value:
47.3B
EV / Invested capital:
--
Price / LTM sales:
23.42x
EV / EBIT:
122.07x
EV / Revenue:
22.70x
PEG ratio (5yr expected):
1.23x
EV / Free cash flow:
143.56x
Price / Operating cash flow:
148.10x
Enterprise value / EBITDA:
108.51x
Gross Profit (TTM):
$1.2B
Return On Assets:
9.77%
Net Income Margin (TTM):
18.05%
Return On Equity:
19.22%
Return On Invested Capital:
14.27%
Operating Margin:
-2.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.6B | $2.1B | $430.4M | $575.1M | |
| Gross Profit | $726.1M | $956.9M | $1.2B | $264M | $345.8M | |
| Operating Income | $93M | $157M | $57.5M | $42.7M | -$15.8M | |
| EBITDA | $116.1M | $184.9M | $436M | $64M | $104.1M | |
| Diluted EPS | $2.04 | $2.33 | $4.79 | $0.75 | $1.67 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $982M | $1.1B | $1.8B | $2.4B | $2.3B | |
| Total Assets | $1.4B | $1.7B | $2.9B | $3.4B | $4.5B | |
| Current Liabilities | $256.3M | $418.5M | $602.6M | $761.5M | $997.6M | |
| Total Liabilities | $404.8M | $640.4M | $1.6B | $1.8B | $2.1B | |
| Total Equity | $976.3M | $1B | $1.3B | $1.6B | $2.3B | |
| Total Debt | -- | -- | $674M | $677.1M | $680.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $235.4M | $189.3M | $408.3M | $140M | $250.2M | |
| Cash From Investing | -$831M | $12.5M | -$490.6M | $53.2M | -$441.7M | |
| Cash From Financing | $598.1M | $41.3M | -$45.4M | -$3.8M | -$32.8M | |
| Free Cash Flow | $179.6M | $129.6M | $329.5M | $116M | $225.4M | |
AXON
Sector
Market Cap
$47.6B
$585.2M
Price % of 52-Week High
86.79%
73.78%
Dividend Yield
0%
0%
Shareholder Yield
-0%
2.4%
1-Year Price Total Return
95.07%
-7.27%
Beta (5-Year)
1.239
0.781
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$611.50
200-day SMA
Buy
Level
$510.32
Bollinger Bands (100)
Buy
Level
537.76 - 638.74
Chaikin Money Flow
Sell
Level
-586.3M
20-day SMA
Buy
Level
$576.83
Relative Strength Index (RSI14)
Buy
Level
63.10
ADX Line
Buy
Level
11.54
Williams %R
Sell
Level
-15.8219
50-day SMA
Buy
Level
$554.06
MACD (12, 26)
Buy
Level
18.58
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
1.2B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (14.0807)
Buy
CA Score
(Annual)
Level (0.1873)
Sell
Beneish M-Score
(Annual)
Level (-1.7751)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.3198)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, productivity and real-time operations software, body cameras, in-car cameras, TASER energy devices, drones and robotic security, and training solutions. The company's operation comprises of two operating segments, Software and Sensors, and TASER. The company generates the majority of its revenue from the Software and Sensors segment, which is engaged in developing, manufacturing, and selling fully integrated hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Stock Forecast FAQ
In the current month, AXON has received 7 Buy ratings 3 Hold ratings, and 0 Sell ratings. The AXON average analyst price target in the past 3 months is $665.10.
-
Where Will Axon Enterprise Stock Be In 1 Year?
According to analysts, the consensus estimate is that Axon Enterprise share price will rise to $665.10 per share over the next 12 months.
-
What Do Analysts Say About Axon Enterprise?
Analysts are divided on their view about Axon Enterprise share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Axon Enterprise is a Sell and believe this share price will drop from its current level to $491.36.
-
What Is Axon Enterprise's Price Target?
The price target for Axon Enterprise over the next 1-year time period is forecast to be $665.10 according to 10 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is AXON A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Axon Enterprise is a Buy. 7 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AXON?
You can purchase shares of Axon Enterprise via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Axon Enterprise shares.
-
What Is The Axon Enterprise Share Price Today?
Axon Enterprise was last trading at $601.35 per share. This represents the most recent stock quote for Axon Enterprise. Yesterday, Axon Enterprise closed at $621.40 per share.
-
How To Buy Axon Enterprise Stock Online?
In order to purchase Axon Enterprise stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 113.25% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 10.85% over the past day.
